Biophysiologic considerations in cryoablation: a practical mechanistic molecular review
- PMID: 22233999
- DOI: 10.1590/s1677-55382011000600002
Biophysiologic considerations in cryoablation: a practical mechanistic molecular review
Abstract
Cryotherapy techniques date back as far as the mid-1800s, when James Arnott demonstrated the effectiveness of salt/ice mixtures in palliation of breast, uterine, and skin cancers. Subsequent advances saw the use of liquid air and solid carbon dioxide in the treatment of various conditions, particularly benign dermatologic lesions (1). Cooper and Lee introduced the first automated cryosurgical apparatus cooled by circulating liquid nitrogen in 1961 and initially used it for treating neuromuscular disorders (2). Liquid nitrogen probes were soon being used in the treatment of benign prostatic hypertrophy and prostate cancer, though complications were quite common, resulting in the procedures falling out of favor until the 1990s, when intraoperative ultrasound techniques were developed, allowing more accurate monitoring of the freezing process (1). The advent of "third-generation" argon and helium gas probes in 2000 and preoperative computer thermal mapping techniques have allowed even more precise placement, temperature control, and further reduction in post-procedural morbidity (3). Cryosurgical techniques are currently used to treat a wide variety of conditions, but significant urologic indications include treatment of low and intermediate risk prostate cancer and renal cell carcinoma < 4 cm in diameter.
Similar articles
-
Cryoablation of renal and prostate tumors.J Endourol. 2003 Oct;17(8):627-32. doi: 10.1089/089277903322518635. J Endourol. 2003. PMID: 14622482 Review.
-
Single center experience with third-generation cryosurgery for management of organ-confined prostate cancer: critical evaluation of short-term outcomes, complications, and patient quality of life.J Endourol. 2007 Dec;21(12):1521-31. doi: 10.1089/end.2007.9875. J Endourol. 2007. PMID: 18186694
-
The cryobiology of cryosurgical injury.Urology. 2002 Aug;60(2 Suppl 1):40-9. doi: 10.1016/s0090-4295(02)01683-7. Urology. 2002. PMID: 12206847 Review.
-
History of cryosurgery.Semin Surg Oncol. 1998 Mar;14(2):99-109. doi: 10.1002/(sici)1098-2388(199803)14:2<99::aid-ssu2>3.0.co;2-1. Semin Surg Oncol. 1998. PMID: 9492880 Review.
-
Cryosurgery as a treatment for prostate carcinoma: results and complications.Cancer. 1997 Mar 1;79(5):963-74. Cancer. 1997. PMID: 9041159
Cited by
-
A histological evaluation and in vivo assessment of intratumoral near infrared photothermal nanotherapy-induced tumor regression.Int J Nanomedicine. 2014 Nov 5;9:5093-102. doi: 10.2147/IJN.S60648. eCollection 2014. Int J Nanomedicine. 2014. PMID: 25395847 Free PMC article.
-
Assessment of Local Tumor Progression After Image-Guided Thermal Ablation for Renal Cell Carcinoma.Korean J Radiol. 2024 Jan;25(1):33-42. doi: 10.3348/kjr.2023.0676. Korean J Radiol. 2024. PMID: 38184767 Free PMC article. Review.
-
Aneurysmal Bone Cyst of the Pelvis in Children and Adolescents: Effectiveness of Surgical Treatment with Curettage, Cryotherapy and Bone Grafting.Healthcare (Basel). 2023 Sep 30;11(19):2658. doi: 10.3390/healthcare11192658. Healthcare (Basel). 2023. PMID: 37830695 Free PMC article.
-
Focal Cryotherapy in Low-Risk Prostate Cancer: Are We Treating the Cancer or the Mind? - The Cancer.Int Braz J Urol. 2015 Jan-Feb;41(1):5-9. doi: 10.1590/S1677-5538.IBJU.2015.01.02. Int Braz J Urol. 2015. PMID: 25928504 Free PMC article. No abstract available.
-
Cryoablation and Immunotherapy: An Enthralling Synergy to Confront the Tumors.Front Immunol. 2019 Sep 24;10:2283. doi: 10.3389/fimmu.2019.02283. eCollection 2019. Front Immunol. 2019. PMID: 31608067 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical